Among patients in the PREvention oF thromboembolic events—European Registry in Atrial Fibrillation (PREFER in AF) registry, insulin users, but not diabetic patients treated with non-insulin antihyperglycemic drugs, were shown to have a higher risk of stroke compared with non-diabetic individuals [13]. This evidence concerns the gene INS and atrial fibrillation.